{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA065129"
        ],
        "brand_name": [
          "CEFIXIME"
        ],
        "generic_name": [
          "CEFIXIME"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-405",
          "68180-407",
          "68180-416",
          "68180-423"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "CEFIXIME"
        ],
        "rxcui": [
          "309058",
          "409823",
          "419849"
        ],
        "spl_id": [
          "735f86f4-369c-4f5a-adbe-7dacea2e27b4"
        ],
        "spl_set_id": [
          "6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"
        ],
        "package_ndc": [
          "68180-405-01",
          "68180-407-03",
          "68180-407-04",
          "68180-416-08",
          "68180-416-11",
          "68180-423-11",
          "68180-423-08"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368180423089",
          "0368180407034",
          "0368180416081",
          "0368180416111"
        ],
        "unii": [
          "97I1C92E55"
        ]
      },
      "product_type": "Drugs",
      "event_id": "93730",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0274-2024",
      "product_description": "Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01",
      "product_quantity": "4,608 Bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications",
      "recall_initiation_date": "20240103",
      "center_classification_date": "20240126",
      "termination_date": "20241227",
      "report_date": "20240207",
      "code_info": "Lot #: F304833, Exp 06/2025",
      "more_code_info": ""
    }
  ]
}